Non-alcoholic fatty liver disease in type 1 diabetes: prevalence and pathophysiology
ContributorsMemaj, Plator; Jornayvaz, François
Published inFrontiers in endocrinology, vol. 13, 1031633
Errata
- An omission to the funding section of the original article was made in error. The following sentence has been added: “Open access funding was provided by the University of Geneva”. The original version of this article has been updated.
- DOI : 10.3389/fendo.2023.1172597
- PMID : 36992808
Publication date2022-12-01
First online date2022-12-01
Abstract
Keywords
- NAFLD
- Glycogenic hepatopathy
- Pathophysiology
- Prevalence
- Type 1 diabetes
- Diabetes Mellitus, Type 1 / complications
- Diabetes Mellitus, Type 1 / epidemiology
- Diabetes Mellitus, Type 2 / complications
- Humans
- Hyperglycemia / complications
- Hyperglycemia / epidemiology
- Metabolic Syndrome / epidemiology
- Non-alcoholic Fatty Liver Disease / complications
- Non-alcoholic Fatty Liver Disease / epidemiology
- Non-alcoholic Fatty Liver Disease / metabolism
- Prevalence
- Risk Factors
Affiliation
Citation (ISO format)
MEMAJ, Plator, JORNAYVAZ, François. Non-alcoholic fatty liver disease in type 1 diabetes: prevalence and pathophysiology. In: Frontiers in endocrinology, 2022, vol. 13, p. 1031633. doi: 10.3389/fendo.2022.1031633
Main files (1)
Article (Published version)
Updates (1)
Erratum
Identifiers
- PID : unige:169244
- DOI : 10.3389/fendo.2022.1031633
- PMID : 36531463
- PMCID : PMC9752856
ISSN of the journal1664-2392